Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Dapagliflozin improved blood sugar control in a man with Werner syndrome without side effects.

Some drugs can cause changes to your hair.

Nilotinib can cause generalized keratosis pilaris.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

TRPV3 in skin cells causes inflammation and cell death.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Neuregulin3 affects cell development in the skin and mammary glands.

Activating TRPV3 reduces skin oil production and increases inflammation, potentially causing dry skin issues.

Enhancing CD8+ T cell function to induce ferroptosis in tumor cells may help treat skin melanoma.

Dermoscopy is an effective tool for accurately detecting skin cancers.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

Nanotechnology improves CRISPR-Cas9 delivery for cancer treatment, but challenges remain.

A woman with childhood growth hormone deficiency had multiple hormone deficiencies and developed serious lung and kidney problems later in life.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Patients with non-small-cell lung cancer need significant survival gains to accept severe side effects.

Chemotherapy regimens were appropriate, but managing adverse effects like anemia and hair loss is crucial.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

The TRPV3 ion channel is important for skin and hair health and could be a target for treating skin conditions.

The research identified key molecules that help hair matrix and dermal papilla cells communicate and influence hair growth in cashmere goats.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Interleukin-1 increases keratin K6 production in skin cells.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Blocking TRPV3 may help treat itch in dry skin conditions.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Stress keratins are expressed less in diseased skin and are linked to differentiation, inflammation, and immunity.

Betacellulin helps blood vessel growth in wounds but delays hair growth.

Basal cell carcinomas and squamous cell carcinomas have different gene activity patterns, suggesting unique treatment approaches.

Ion channels play a key role in ovarian cancer growth and treatment resistance.

Osthole inhibits the TRPV3 channel by binding to specific sites, potentially aiding drug development for skin diseases and cancers.